Newsroom

Press Releases and Media Coverage

Press Release
April 19 2022
Verismo Therapeutics Expands Scientific Team to Advance its KIR-CAR Platform for the Treatment of Solid Tumors
MORE >
Media Coverage
February 14 2022
Verismo Therapeutics, Inc., Enters into Master Translational Research Services Agreement with the University of Pennsylvania
MORE >
Media Coverage
January 6 2022
Penn Spinout Verismo Therapeutics Trying to Skirt T-Cell Exhaustion in Cell Therapy for Solid Cancer
MORE >
Press Release
December 15 2021
Biopharma charts progress in translating CAR-T cell therapies to solid cancers
MORE >
Press Release
November 9 2021
Verismo Therapeutics Appoints Steven Albelda, MD, to Scientific Advisory Board
MORE >
Press Release
October 13 2021
Verismo Therapeutics Appoints Laura Johnson, Ph.D. as Chief Scientific Officer
MORE >